What is Mounjaro for Weight Loss Called? Understanding Its Role in Weight Management

Last reviewed: July 7, 2026

Last updated: July 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro contains tirzepatide, a medication originally developed for type 2 diabetes that has shown remarkable weight loss results in clinical trials. When used off-label for weight management, tirzepatide is often called a GLP-1 medication, though it functions as a dual GLP-1/GIP receptor agonist—meaning it targets two separate appetite-regulation pathways in the brain simultaneously. PlexusDx provides access to compounded tirzepatide through licensed 503A pharmacies across all 50 states.

The Clinical Name: Tirzepatide and Its Dual Action

Tirzepatide is the generic pharmaceutical name for Mounjaro's active ingredient. Unlike single-pathway GLP-1 medications like semaglutide, tirzepatide activates both glucagon-like peptide-1 (GLP-1) receptors and glucose-dependent insulinotropic polypeptide (GIP) receptors. This dual activation creates a more comprehensive effect on hunger signals, satiety cues, and metabolic rate. In the SURMOUNT clinical trials, participants taking tirzepatide experienced an average weight loss of 21-22% of their baseline body weight over 72 weeks.

The medication works by slowing gastric emptying—meaning food stays in your stomach longer—and directly signaling the brain's appetite centers that you feel fuller faster. The GIP component adds an additional metabolic benefit by improving insulin sensitivity and promoting fat oxidation. PlexusDx offers compounded tirzepatide injections that deliver the same active mechanism at a flat monthly cost of $289, with your dose able to increase without raising your price.

Why Tirzepatide Is Called a GLP-1 Medication for Weight Loss

In common medical and consumer language, tirzepatide is often grouped with GLP-1 medications because it includes GLP-1 receptor activation as a key part of its mechanism. Healthcare providers and patients frequently refer to both tirzepatide and semaglutide as 'GLP-1 drugs' even though tirzepatide is technically a GLP-1/GIP dual agonist. This shorthand reflects the dominant role of the GLP-1 pathway in appetite suppression and the way these medications function within the broader category of peptide-based weight management agents.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, and GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Tirzepatide vs. Semaglutide: Understanding the Difference

Semaglutide (Ozempic, Wegovy) is a single GLP-1 receptor agonist—it activates only one appetite pathway. Tirzepatide activates two pathways simultaneously: GLP-1 and GIP. This structural difference translates into greater average weight loss with tirzepatide in head-to-head comparisons. Clinical data shows tirzepatide users lost approximately 3-5% more body weight than semaglutide users at equivalent timepoints, though individual response varies significantly based on genetics and lifestyle factors.

PlexusDx offers both options: compounded semaglutide injection (starting at $189/mo (or $149/mo on the 6-month plan)) and compounded tirzepatide injection (starting at $289/mo (or $249/mo on the 6-month plan)). Neither your dose may need to go up - your price won't adjusts—the commitment is to flat-rate pricing regardless of escalation. Some patients respond better to the single GLP-1 pathway, while others benefit from dual activation. The Precision Peptide Genetic Test ($99 add-on after your first treatment month) analyzes your GLP1R and GIPR variants to help guide which mechanism may work best for your unique biology.

Accessing Compounded Tirzepatide Through PlexusDx

PlexusDx provides compounded tirzepatide injections manufactured by licensed 503A compounding pharmacies—the same regulatory standard as hospital and clinical compounding operations. All medications are prepared to exacting quality standards and shipped directly to your home. No insurance is required, no membership fees apply, and coverage is available across all 50 states. HSA and FSA accounts are eligible for payment, and your subscription can be paused or adjusted at any time.

The flat-rate pricing model—$249 per month for tirzepatide injection—means you can begin at a lower starting dose and increase your strength as your body adapts, without worrying about escalating costs. This approach removes the financial barrier many patients face when stepping up therapy. PlexusDx also offers oral tirzepatide ($349/month) and the GLP-Squared dual-compound injection combining semaglutide and tirzepatide ($289/month) for patients seeking maximum peptide pathway activation.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is Mounjaro the same thing as tirzepatide?

Yes. Mounjaro is the brand name manufactured by Eli Lilly; tirzepatide is the generic pharmaceutical name for its active ingredient. PlexusDx sources compounded tirzepatide from licensed 503A pharmacies, offering the same active compound at a flat $289 monthly rate regardless of dose strength.

Why do doctors call tirzepatide a GLP-1 medication if it's also a GIP agonist?

Tirzepatide is often grouped with GLP-1 medications because GLP-1 receptor activation is a primary component of its mechanism and the dominant driver of appetite suppression. The GIP receptor activation is the distinguishing dual-pathway feature that makes tirzepatide more potent than single-pathway GLP-1 agents. Medical professionals use both precise and colloquial terms depending on context.

Does PlexusDx charge more for higher doses of tirzepatide?

No. PlexusDx maintains flat-rate monthly pricing at $289 for compounded tirzepatide injection. Your dose may increase as your body adapts, but your monthly cost remains the same—reflecting the company's commitment to predictable, transparent pricing for weight loss therapy.

Is compounded tirzepatide as safe as brand-name Mounjaro?

Compounded tirzepatide from licensed 503A pharmacies meets rigorous pharmaceutical standards. While brand-name Mounjaro carries FDA approval for diabetes, compounded tirzepatide prepared by 503A facilities undergoes the same quality controls. Both carry similar side effect profiles—primarily nausea, vomiting, and injection-site reactions—and should be monitored by a healthcare provider.

Can the Precision Peptide Genetic Test help me choose between tirzepatide and semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, and GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.